4931-Twigg III, Homer

Homer L. Twigg III, MD

Floyd and Reba Smith Professor of Pulmonary Disease

Professor of Medicine

Address
Willis Gatch Hall, CL 260
1120 W. Michigan St.
CL 260
Indianapolis, IN 46202
PubMed:

Bio

Homer L. Twigg III, M.D. is a Professor of Medicine in the Pulmonary, Allergy, Critical Care, and Sleep Medicine Division at Indiana University. Dr. Twigg did his Medical School training at Georgetown University, Internal Medicine Residency at the University of Alabama at Birmingham, and Pulmonary/Critical Care Fellowship at the University of Texas Health Science Center at Dallas (Parkland). He joined the faculty at Indiana University in 1989 and served as the Chief of the Division 2000 to 2017. Dr. Twigg has a long research interest in pulmonary host defense in HIV infection and has served on many special emphasis panels sponsored by the NHLBI in this area. He also served a term as a standing member of the Lung Cellular, Molecular, and Immunobiology (LCMI) study section.  Dr. Twigg has been investigating the lung Microbiome and Virome in healthy subjects and patients with HIV infection, attempting to link the microbial milieu to chronic inflammation and chronic diseases found in the HIV-infected and aging population.  These concepts have led to his current area of research investigating how viral persistence, even by viruses not known to cause latency, can lead to chronic immune stimulation and chronic disease.  This work has led to Dr. Twigg’s most recent NIH funding to study post-COVID lung disease, hypothesizing that SARS-CoV-2 proteins and RNA persist in extracellular vesicles and are capable of eliciting an immune and inflammatory response leading to delayed cryptogenic organizing pneumonia and pulmonary fibrosis in these patients.

Key Publications

Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects.
Twigg HL III, M Weiden, F Valentine, CT Schnizlein-Bick, R Basset, L Zheng, J Wheat, RB Day, H Rominger, R Collman, L Fox, R Coombs, RP Bucy, for the Adult AIDS Clinical Trials Group Protocol 723 Team. J Inf Dis 197:109-116, 2008.
 
Compromised Immunity and the Microbiome – Transplantation, Cancer, and HIV
Bernasconi, E, JD Aubert, A Koutsokera, L Nicod, HL Twigg III.  Compromised Immunity and the Microbiome – Transplantation, Cancer, and HIV.  European Resp Soc Monograph.  83:195-215; 2019.
 
Effect of Advanced HIV Infection on the Respiratory Microbiome.
Twigg HL III, KS Knox, J Zhou, KA Crothers, DE Nelson, E Toh, RB Day, H Lin, X Gao, Q Dong, D Mi, BP Katz, E Sodergren, GM Weinstock.  Am J Respir Crit Care Med 194:226-235, 2016.
 
Mortality Rates in a Diverse Cohort of Mechanically Ventilated Patients With Novel Coronavirus in the Urban Midwest
Twigg HL III, SH Khan, AJ Perkins, S Roberts, CR Sears, O Rahman, JP Smith, R Kapoor, MO Farber, T Ellender, WG Carlos, G Gilroy, J Buckley, G Bosslet, R Machado, S Gao, BA Khan.  Mortality Rates in a Diverse Cohort of Mechanically Ventilated Patients with Novel Coronavirus in the Urban Midwest.  Crit Care Expl 2:e0187; 2020.  PMID:  32903962.
 
Supraglottic Lung Microbiome Taxa Are Associated with Pulmonary Abnormalities in an HIV Longitudinal Cohort
Zhou JJ, J Zhai, H Zhou, Y Chen, S Guerra, I Robey, GM Weinstock, E Sodergren, Q Dong, KS Knox, HL Twigg III.  Supraglottic Lung Microbiome Taxa Are Associated with Lung Inflammation and Pulmonary Function Abnormalities in an HIV Infected Longitudinal Cohort. Am J Respir Crit Care Med 202:1727-1731; 2020.  PMID:  32783620.
 

Looking for patient care?

To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.